Trial
NCT02268825
Phase I Study MK-3475 With Chemotherapy in Patients With Advanced GI Cancers
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Utah
Collaborators
Merck Sharp & Dohme LLC
Condition
Advanced GI Cancer
Intervention
MK-3475
Why stopped
Merck requested to change MK-3475 dosing schedule; PI decided to close instead
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-11-13